As part of its commitment to investing in translational science that significantly improves the lives of patients, UPMC has launched Novasenta, a drug discovery and development company seeking novel and effective treatments for cancer. Mani Mohindru, Ph.D., Novasenta CEOBased on years of cancer research by renowned University of Pittsburgh scientists and a machine-learning-enabled platform that […]